| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.42 | 0.002 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |